Αρχική World News FDA Approves Treosulfan with Fludarabine As a Preparative Regimen for alloHSCT in... World News FDA Approves Treosulfan with Fludarabine As a Preparative Regimen for alloHSCT in Adult and Paediatric Patients with AML or MDS Από Ogkologos - 13 Μαρτίου, 2025 982 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the MC-FludT.14/L Trial II Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Dabrafenib–Trametinib Combination Approved for Solid Tumors with BRAF Mutations 21 Ιουλίου, 2022 Coping With Life After a Bone Marrow Transplant: A Survivor’s Story 15 Αυγούστου, 2023 Better together: improving brain tumour treatment 13 Φεβρουαρίου, 2023 Novel Checklist for Quality of Life to Bring ESMO-MCBS and Clinical... 20 Δεκεμβρίου, 2022 Φόρτωση περισσοτέρων HOT NEWS Pazopanib Is Not Inferior to Doxorubicin in First-Line Treatment of Elderly... How I Rebuilt My Self-Image After a Laryngectomy: A Cancer Survivor’s... Malaria Vaccine Approved by W.H.O. Could Save Tens Of Thousands Of... Ahead of a Key Meeting of EU Health Ministers, ESMO Calls...